市場調查報告書
商品編碼
1354320
疼痛管理藥物市場規模 - 按藥物類別、適應症、疼痛類型、分銷管道、全球預測Pain Management Drugs Market Size - By Drug Class, Indication, Pain Type, Distribution Channel, Global Forecast |
2023 年至 2032 年,全球疼痛管理藥物市場規模預計複合年成長率為 4.5%。
製藥公司擴大研發投資以創造新型疼痛管理藥物和製劑以提高療效並減少副作用將推動產業成長。舉個例子,2023 年 7 月,EuroAPI 的受管制物質子公司 Francopia 投資了 7,600 萬美元,用於提高其位於法國 Vertolaye 工廠的止痛活性藥物成分的生產。為提高止痛藥的有效性和安全性而不斷進行的給藥系統創新也將影響產品需求。
整個疼痛管理藥物市場根據藥物類別、適應症、疼痛類型、分銷管道和地區進行細分。
就適應症而言,關節炎疼痛領域的疼痛管理藥物產業從 2023 年到 2032 年可能會錄得可觀的複合年成長率。這是由於緩解和消除與關節炎相關的疼痛的需求不斷增加。根據疾病預防和健康促進辦公室的數據,到2040 年,受關節炎影響的成年人數量預計將增加到7,840 萬人。因此,擴大使用疼痛管理藥物來治療關節炎疼痛,以限制不適並提高生活品質將促進市場成長。
根據分銷管道,線上藥局市場的市場價值預計將擴大到 2032 年。這一成長可歸因於人們對線上藥局的日益青睞,因為它們為人們提供便利、可及性和廣泛的止痛藥物。尋求緩解多種疼痛的消費者。與遠距醫療服務的日益整合,使患者能夠線上上諮詢醫療保健提供者並獲得處方,也將有助於該細分市場的擴張。
從地區來看,由於越來越重視以患者為中心的護理和神經調節技術等更高的技術進步,預計到 2032 年,亞太地區疼痛管理藥物市場規模將創下顯著的複合年成長率。醫療保健基礎設施的不斷改善以及醫療服務的普及使得該地區疼痛疾病的診斷和治療得到了更好的發展,進一步推動了人們對疼痛管理藥物的偏好。
Global Pain Management Drugs Market size is poised to record 4.5% CAGR from 2023-2032.
The scaling R&D investments by pharmaceutical companies for creating novel pain management drugs and formulations for enhanced efficacy and reduced side effects will drive the industry growth. To cite an instance, in July 2023, EuroAPI's controlled substance unit Francopia invested $76 million in a project for boosting the production of pain relief active pharmaceutical ingredients at its plant in Vertolaye, France. The growing innovations in drug delivery systems to improve the effectiveness as well as safety of pain medications will also influence the product demand.
The overall pain management drugs market is segmented based on drug class, indication, pain type, distribution channel, and region.
In terms of indication, the pain management drugs industry from the arthritic pain segment may record appreciable CAGR from 2023-2032. This is due to the rising need to alleviate and eliminate pain associated with arthritis. According to the Office of Disease Prevention and Health Promotion, the number of arthritis-affected adults is projected to rise to 78.4 million by 2040. Hence, the increasing usage of pain management drugs for arthritic pain to limit the discomfort and enhance the quality of life will add to the market growth.
On the basis of distribution channel, the market value from the online pharmacies segment is expected to expand up to 2032. The growth can be attributed to the growing preference for online pharmacies as they offer convenience, accessibility, and wide range of pain relief medications to consumers seeking relief from several types of pain. The increasing integration with telemedicine services to enable patients to consult with healthcare providers online as well as receive prescriptions will also contribute to the segment expansion.
Regionally, APAC pain management drugs market size is projected to record notable CAGR through 2032 due to the rising emphasis on patient-centric care and higher technological advancements, such as neuromodulation techniques. Increasing improvements in healthcare infrastructure as well as access to medical services has led to better diagnosis and treatment of pain conditions in the region, further driving the preference for pain management drugs.